104 related articles for article (PubMed ID: 22855610)
1. Inhibition of apoptosis by BCL2 prevents leukemic transformation of a murine myelodysplastic syndrome.
Slape CI; Saw J; Jowett JB; Aplan PD; Strasser A; Jane SM; Curtis DJ
Blood; 2012 Sep; 120(12):2475-83. PubMed ID: 22855610
[TBL] [Abstract][Full Text] [Related]
2. Targeting miR-126 disrupts maintenance of myelodysplastic syndrome stem and progenitor cells.
Wang H; Sun J; Zhang B; Zhao D; Tong H; Wu H; Li X; Luo Y; Dong D; Yao Y; McDonald T; Stein AS; Al Malki MM; Pichiorri F; Carlesso N; Kuo YH; Marcucci G; Li L; Jin J
Clin Transl Med; 2021 Oct; 11(10):e610. PubMed ID: 34709739
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibition of MCL1 overcomes venetoclax resistance in a murine model of myelodysplastic syndromes.
Fischer MA; Song Y; Arrate MP; Gbyli R; Villaume MT; Smith BN; Childress MA; Stricker TP; Halene S; Savona MR
Haematologica; 2023 Feb; 108(2):522-531. PubMed ID: 35979721
[TBL] [Abstract][Full Text] [Related]
4. Single-cell transcriptomics dissects the transcriptome alterations of hematopoietic stem cells in myelodysplastic neoplasms.
Zeng X; Wang Y; Dai M; Li W; Huang Q; Qin L; Li Y; Yan Y; Xue X; Yi F; Li W; He L; Liu Q; Qi L
J Transl Med; 2024 Apr; 22(1):359. PubMed ID: 38632656
[TBL] [Abstract][Full Text] [Related]
5. Stem cell concepts in myelodysplastic syndromes: lessons and challenges.
Woll PS; Jacobsen SEW
J Intern Med; 2021 May; 289(5):650-661. PubMed ID: 33843081
[TBL] [Abstract][Full Text] [Related]
6. Apoptotic rate in patients with myelodisplastic syndrome treated with modulatory compounds of pro-apoptotic cytokines.
Moldoveanu E; Moicean A; Vidulescu C; Marta D; Colita A
J Cell Mol Med; 2003; 7(3):313-21. PubMed ID: 14594556
[TBL] [Abstract][Full Text] [Related]
7. Integrative analysis of next generation sequencing for small non-coding RNAs and transcriptional regulation in Myelodysplastic Syndromes.
Beck D; Ayers S; Wen J; Brandl MB; Pham TD; Webb P; Chang CC; Zhou X
BMC Med Genomics; 2011 Feb; 4():19. PubMed ID: 21342535
[TBL] [Abstract][Full Text] [Related]
8. Sequential gene expression analysis of myelodysplastic syndrome transformation identifies HOXB3 and HOXB7 as the novel targets for mesenchymal cells in disease.
Yin C; Li Y; Zhang C; Zang S; Wang Z; Yan X; Ma T; Li X; Li W
BMC Cancer; 2024 Jan; 24(1):111. PubMed ID: 38254070
[TBL] [Abstract][Full Text] [Related]
9. Initial transforming event in myelodysplastic syndromes may be viral: case for cytomegalovirus.
Raza A
Med Oncol; 1998 Sep; 15(3):165-73. PubMed ID: 9819793
[TBL] [Abstract][Full Text] [Related]
10. Characterization of transcriptional networks in blood stem and progenitor cells using high-throughput single-cell gene expression analysis.
Moignard V; Macaulay IC; Swiers G; Buettner F; Schütte J; Calero-Nieto FJ; Kinston S; Joshi A; Hannah R; Theis FJ; Jacobsen SE; de Bruijn MF; Göttgens B
Nat Cell Biol; 2013 Apr; 15(4):363-72. PubMed ID: 23524953
[TBL] [Abstract][Full Text] [Related]
11. Development of MDS in Pediatric Patients with GATA2 Deficiency: Increased Histone Trimethylation and Deregulated Apoptosis as Potential Drivers of Transformation.
Schreiber F; Piontek G; Schneider-Kimoto Y; Schwarz-Furlan S; De Vito R; Locatelli F; Gengler C; Yoshimi A; Jung A; Klauschen F; Niemeyer CM; Erlacher M; Rudelius M
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067298
[TBL] [Abstract][Full Text] [Related]
12. Attenuated cell cycle and DNA damage response transcriptome signatures and overrepresented cell adhesion processes imply accelerated progression in patients with lower-risk myelodysplastic neoplasms.
Kaisrlikova M; Kundrat D; Koralkova P; Trsova I; Lenertova Z; Votavova H; Merkerova MD; Krejcik Z; Vesela J; Vostry M; Simeckova R; Markova MS; Lauermannova M; Jonasova A; Cermak J; Divoky V; Belickova M
Int J Cancer; 2024 May; 154(9):1652-1668. PubMed ID: 38180088
[TBL] [Abstract][Full Text] [Related]
13. BCL2: a 30-year tale of life, death and much more to come.
Pentimalli F
Cell Death Differ; 2018 Jan; 25(1):7-9. PubMed ID: 29125600
[No Abstract] [Full Text] [Related]
14. Transforming growth factor-β superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis.
Suragani RN; Cadena SM; Cawley SM; Sako D; Mitchell D; Li R; Davies MV; Alexander MJ; Devine M; Loveday KS; Underwood KW; Grinberg AV; Quisel JD; Chopra R; Pearsall RS; Seehra J; Kumar R
Nat Med; 2014 Apr; 20(4):408-14. PubMed ID: 24658078
[TBL] [Abstract][Full Text] [Related]
15. Loss of p53 accelerates the complications of myelodysplastic syndrome in a NUP98-HOXD13-driven mouse model.
Xu H; Menendez S; Schlegelberger B; Bae N; Aplan PD; Göhring G; Deblasio TR; Nimer SD
Blood; 2012 Oct; 120(15):3089-97. PubMed ID: 22927245
[TBL] [Abstract][Full Text] [Related]
16. Hemolysis-driven IFNα production impairs erythropoiesis by negatively regulating EPO signaling in sickle cell disease.
Han Y; Gao C; Liu Y; Zhang H; Wang S; Zhao H; Bao W; Guo X; Vinchi F; Lobo C; Shi P; Mendelson A; Luchsinger L; Zhong H; Yazdanbakhsh K; An X
Blood; 2024 Mar; 143(11):1018-1031. PubMed ID: 38127913
[TBL] [Abstract][Full Text] [Related]
17. LRIG2 regulates cell proliferation, migration and apoptosis of osteosarcoma.
Li ZQ; Liao WJ; Sun BL; Luo ZW; Zhong NS; Wu JB; Liu ZL; Liu JM
BMC Cancer; 2022 Oct; 22(1):1029. PubMed ID: 36183058
[TBL] [Abstract][Full Text] [Related]
18. The BH3-only protein NOXA serves as an independent predictor of breast cancer patient survival and defines susceptibility to microtubule targeting agents.
Karbon G; Haschka MD; Hackl H; Soratroi C; Rocamora-Reverte L; Parson W; Fiegl H; Villunger A
Cell Death Dis; 2021 Dec; 12(12):1151. PubMed ID: 34903710
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic insights and potential therapeutic approaches for NUP98-rearranged hematologic malignancies.
Michmerhuizen NL; Klco JM; Mullighan CG
Blood; 2020 Nov; 136(20):2275-2289. PubMed ID: 32766874
[TBL] [Abstract][Full Text] [Related]
20. TLR2/6 signaling promotes the expansion of premalignant hematopoietic stem and progenitor cells in the NUP98-HOXD13 mouse model of MDS.
Monlish DA; Greenberg ZJ; Bhatt ST; Leonard KM; Romine MP; Dong Q; Bendesky L; Duncavage EJ; Magee JA; Schuettpelz LG
Exp Hematol; 2020 Aug; 88():42-55. PubMed ID: 32652111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
